Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1118.93%
↑ 15% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-1319.90%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1118.93% | -6.0% |
| 2024 | -1055.45% | -55.0% |
| 2023 | -680.84% | +89.3% |
| 2022 | -6384.05% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |